
### [NCIT:C4843](http://purl.obolibrary.org/obo/NCIT_C4843)
**Label:** Biliary Intraepithelial Neoplasia

**Subclasses:** [NCIT:C43606](http://purl.obolibrary.org/obo/NCIT_C43606) (Gallbladder Biliary Intraepithelial Neoplasia), [NCIT:C96942](http://purl.obolibrary.org/obo/NCIT_C96942) (Extrahepatic Bile Duct Biliary Intraepithelial Neoplasia), [NCIT:C67493](http://purl.obolibrary.org/obo/NCIT_C67493) (Biliary Intraepithelial Neoplasia-3), [NCIT:C96943](http://purl.obolibrary.org/obo/NCIT_C96943) (Intrahepatic Bile Duct Biliary Intraepithelial Neoplasia), [NCIT:C96945](http://purl.obolibrary.org/obo/NCIT_C96945) (Bile Duct Biliary Intraepithelial Neoplasia), [NCIT:C67491](http://purl.obolibrary.org/obo/NCIT_C67491) (Biliary Intraepithelial Neoplasia-1), [NCIT:C67492](http://purl.obolibrary.org/obo/NCIT_C67492) (Biliary Intraepithelial Neoplasia-2), 

**Class expressions from DL-Learner:**

- Thing 53.30%
- [UBERON:0002423](http://purl.obolibrary.org/obo/UBERON_0002423) (hepatobiliary system) 52.94%
- [UBERON:0002294](http://purl.obolibrary.org/obo/UBERON_0002294) (biliary system) 52.94%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39072](http://purl.obolibrary.org/obo/NCIT_C39072) (Erk1/Erk2 MAPK Signaling Pathway))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39071](http://purl.obolibrary.org/obo/NCIT_C39071) (Neuronal Survival Pathway))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39069](http://purl.obolibrary.org/obo/NCIT_C39069) (ErbB3 Receptor Recycling Pathway))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39067](http://purl.obolibrary.org/obo/NCIT_C39067) (EPO Signaling Pathway))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39066](http://purl.obolibrary.org/obo/NCIT_C39066) (Erythropoietin Neuroprotection Pathway))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39059](http://purl.obolibrary.org/obo/NCIT_C39059) (Map Kinase Inactivation of SMRT Corepressor Pathway))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39058](http://purl.obolibrary.org/obo/NCIT_C39058) (EGF Signaling Pathway))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39056](http://purl.obolibrary.org/obo/NCIT_C39056) (Vesicle Transport Pathway))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39055](http://purl.obolibrary.org/obo/NCIT_C39055) (Phospholipid Signaling Pathway))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39054](http://purl.obolibrary.org/obo/NCIT_C39054) (Extracellular Matrix Binding Pathway))) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C39040](http://purl.obolibrary.org/obo/NCIT_C39040) (CTCF Pathway))) 38.30%


